Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL406778 | 1.00 | MGLL (0.47) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL5970022 | 1.00 | MGLL (0.47) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL18840672 | 1.00 | MGLL (0.47) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL11136205 | 0.98 | MGLL (0.44) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL409034 | 0.93 | KDM4E (0.44) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL13864176 | 0.91 | MGLL (0.40) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL13864174 | 0.91 | MGLL (0.56) | MGLLPTGS1PTGS2FAAHMAPT | |
| SCHEMBL13864166 | 0.91 | MAPT (0.43) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL26797334 | 0.89 | MAPT (0.41) | MGLLPTGS1PTGS2FAAHALDH1A1 | |
| SCHEMBL4903716 | 0.85 | CYP19A1 (0.33) | ALDH1A1MAPTGAATHRBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1027 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1075261-B1 | MYCOBACTERIAL INHIBITORS | ASTRAZENECA AB (SE) | 2006-04-12 | — | — | EP | claimed |
| US-6476053-B1 | Mycobacterial inhibitors | ASTRAZENECA AB (SE) | 2002-11-05 | — | — | US | claimed |
| EP-1075261-A1 | MYCOBACTERIAL INHIBITORS | AstraZeneca AB (SE) | 2001-02-14 | — | — | EP | claimed |
| WO-1999065483-A1 | MYCOBACTERIAL INHIBITORS | ASTRAZENECA AB (SE) | 1999-12-23 | — | — | WO | claimed |
| EP-4748899-A1 | ADHESIVE SHEET | Nitto Denko Corporation (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12637595-B2 | Pressure-sensitive adhesive sheet, optical member, and touch panel | NITTO DENKO CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-116368199-B | Pressure-sensitive adhesive sheet | 日东电工株式会社 | 2026-05-12 | — | — | CN | disclosed |
| EP-4737530-A1 | ACTIVE ENERGY RAY-CURABLE ADHESIVE COMPOSITION AND ADHESIVE SHEET | Toagosei Co., Ltd. (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4108732-B1 | HOT-MELT PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND HOT-MELT PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12617985-B2 | Pressure-sensitive adhesive sheet and use thereof | NITTO DENKO CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4733364-A1 | ADHESIVE SHEET, ADHESIVE COMPOSITION, AND DECORATIVE MOLDED BODY | Toagosei Co., Ltd. (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-20260088294-A1 | POSITIVE ELECTRODES AND RECHARGEABLE LITHIUM BATTERIES INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-03-26 | — | — | US | disclosed |
| US-6284369-B1 | HAVING PRESSURE-SENSITIVE ADHESIVE LAYER WITH DISAPPEARANCE PROPERTY AND COLOR RETENTION, ADHESION AFTER BURNING | NITTO DENKO CORPORATION (JP) | 2001-09-04 | — | — | US | disclosed |
| EP-1075261-A1 | MYCOBACTERIAL INHIBITORS | AstraZeneca AB (SE) | 2001-02-14 | — | — | EP | disclosed |
| WO-1999065483-A1 | MYCOBACTERIAL INHIBITORS | ASTRAZENECA AB (SE) | 1999-12-23 | — | — | WO | disclosed |
| US-5962097-A | Protective member for semiconductor wafer | NITTO DENKO CORPORATION (JP) | 1999-10-05 | — | — | US | disclosed |
| EP-0905664-A1 | SHEET FOR FORMING FIRING PATTERN | NITTO DENKO CORPORATION (JP) | 1999-03-31 | — | — | EP | disclosed |
| US-5880800-A | Optical film and liquid crystal display | NITTO DENKO CORPORATION (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0884620-A2 | Liquid crystal display | NITTO DENKO CORPORATION (JP) | 1998-12-16 | — | — | EP | disclosed |
| EP-0881509-A2 | Polarizer, lighting device and liquid crystal display | NITTO DENKO CORPORATION (JP) | 1998-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617985-B2 | Pressure-sensitive adhesive sheet and use thereof | PCNA, CDH1, ACP3 | MGLL 3791/4885PTGS1 1238/4885PTGS2 2151/4885 |
| US-12637595-B2 | Pressure-sensitive adhesive sheet, optical member, and touch panel | LCP1, CDH1, HSPA4L | MGLL 3714/4885PTGS1 409/4885PTGS2 565/4885 |
| US-20260088294-A1 | POSITIVE ELECTRODES AND RECHARGEABLE LITHIUM BATTERIES INCLUDING THE SAME | CACNA2D4, CACNA2D3, CACNA2D1 | MGLL 4574/4885PTGS1 4110/4885PTGS2 3903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.